Adagene Inc. (NASDAQ:ADAG) is facing a pessimistic market outlook with a potential downside of 33.08%, indicating cautious investor sentiment towards its monoclonal antibody drugs for cancer treatment.Adicet Bio, Inc. (NASDAQ:ACET) also shows a negative growth potential with a potential downside of 15.29%, despite leading in target price change among peers, reflecting cautious market sentiment towards its gamma delta T cell therapies.The biotechnology sector's inherent risks and uncertainties contribute to ...

Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments – the first in a string of new planned U.S. investments by the drugmaker. The company announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020. Eli Lilly said it will announce the three remaining U.S. sites t ...